Cardiovascular Disease and Metabolic Risk Factors in Male Patients With Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder

Kilbourne, Amy M.; Brar, Jaspreet S.; Drayer, Rebecca A.; Xu, Xiangyan; Post, Edward P.

doi:10.1176/appi.psy.48.5.412

Cited by 96 publications

(75 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Metabolic syndrome and serum homocysteine in patients with bipolar disorder and There is an accumulating evidence for an increased prevalence of metabolic syndrome (MetS) or its modal subcomponents in bipolar patients (Fagiollini et al, 2005;Cardenas et al, 2008;Vuksan-Ćusa et al, 2009) which is comparable to (Birkenaes et al, 2007;Corell et al, 2008), or even higher (Kilbourne et al, 2007) than the prevalence of MetS in patients with schizophrenia. Homocysteine is non-protein amino acid that occurs in human by the demetilation of nutritional methionine, catalyzed by methyltransferases (Reif et al, 2005).…”

Section: /19mentioning

confidence: 99%

Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics

Vuksan-Ćusa

Jakovljević

Šagud

et al. 2011

Psychiatry Research

View full text Add to dashboard Cite

Section: /19mentioning

confidence: 99%

Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics

Vuksan-Ćusa

Jakovljević

Šagud

et al. 2011

Psychiatry Research

View full text Add to dashboard Cite

“…Persons with SMI have high rates of medical co-morbidity including coronary heart disease, hypertension, diabetes, obesity, and hyperlipidemia (Bartels 2004;Brown 1997;Goff et al 2005;Nasrallah et al 2006;Osborn et al 2006;Sokal et al 2004). For example, the prevalence of cardiovascular disease has been found to be approximately two times the prevalence observed in the general population (Kilbourne et al 2007).…”

Section: Introductionmentioning

confidence: 99%

Use of HIV and Psychotropic Medications among Persons with Serious Mental Illness and HIV/AIDS

Lee

Rothbard

Noll

et al. 2010

Adm Policy Ment Health

View full text Add to dashboard Cite

Persons with serious mental illness (SMI) have higher rates of co-morbid HIV disorders compared to the general population. There are concerns that the SMI/HIV population may be receiving fewer HIV and psychotropic medications due to problems of access and concerns by providers associated with following complex medication regimes. The purpose of this study was to examine any disparity in medication treatment of the SMI/HIV population by comparing medication use and continuity of prescription fills to groups that had HIV or SMI only versus those with SMI/HIV. Study participants were adult Medicaid recipients aged 19-64 with serious mental illness and HIV receiving services in Philadelphia from 2002 through 2003. Differences between the groups in case mix characteristics, medication use rates, and continuity of psychotropic and antiretroviral medication use were compared using Chi-square, t-tests of significance, and logistic regression. Co-morbid individuals were as likely to have filled prescriptions for psychotropic and antiretroviral medications as those with a single disorder and equally persistent in their continuity of antiretroviral medication refills as those with HIV only. However, persons with co-morbid condition had lower continuity of psychotropic medication use compared to those with SMI only. Our findings suggest the need to develop an integrated medical and behavioral healthcare model to improving coordination and treatment for patients with co-occurring disorders. Future research is warranted to investigate the reasons for the discrepancy in continuity of psychotropic adherence for the SMI/HIV population.

show abstract

“…61,62 It has been estimated that the impact of cardiovascular risk factors in patients with severe mental illness, including bipolar affective disorder, is of an order two to three times greater than in the general population. [63][64][65] These considerations emphasise the importance of screening and intervening.…”

Section: Discussionmentioning

confidence: 99%

Blood pressure monitoring in psychiatric inpatients with bipolar affective disorder

Kelbrick¹,

Abdaldayim²

2014

Prog Neurol Psychiatry

View full text Add to dashboard Cite

People with bipolar affective disorder are at increased risk of hypertension, but cardiovascular health screening practices in mental health services are inconsistent and often sub‐optimal. Here, the authors describe their audit to identify adults with bipolar affective disorder and comorbid hypertension in an acute psychiatric inpatient unit, and to establish the unit's level of compliance with local and national guidelines with regard to blood pressure monitoring.

show abstract

Cardiovascular Disease and Metabolic Risk Factors in Male Patients With Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder

Cited by 96 publications

References 32 publications

Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics

Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics

Use of HIV and Psychotropic Medications among Persons with Serious Mental Illness and HIV/AIDS

Blood pressure monitoring in psychiatric inpatients with bipolar affective disorder

Contact Info

Product

Resources

About